Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
Tonix Pharmaceuticals secured a major managed Medicare agreement for TONMYA, adding approximately 9 million Medicare lives effective January 1, 2027. Combined with prior commercial agreements and Medicaid access, the deal expands total pharmacy coverage to roughly 145 million lives, representing 46% of all covered lives in the U.S.
Key figures
- Drug Name
- TONMYA (cyclobenzaprine HCl sublingual tablets)
- Medicare lives added
- 9000000
- Sales force new reps
- 50
- Sales force total target
- 150
- Coverage percentage jan2027
- 46%
- Total covered lives jan2027
- 145000000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.